ArticleRSC advances2024
Magnetic MnFe
Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 22 citations in OpenAlex.
- ZIF-67 and Mn & Zn co-doped ZIF-67 as multifunctional therapeutic platforms: Antibacterial, antioxidant, and anticancer assessment in lung cancer cellsBiomaterials and biosystems · 2026Article
- Enhanced visible-light-driven photocatalytic degradation of methylene blue and ciprofloxacin using magnetic NiFeRSC advances · 2026Article
- Rational Design of Core-Shell MoSNanomaterials (Basel, Switzerland) · 2025Article
- Construction of Z-Scheme ZIF67/NiMoOMaterials (Basel, Switzerland) · 2024Article
- Peroxymonosulfate activation by cobalt-doped ferromanganese magnetic oxides through singlet oxygen and radical pathways for efficient sulfadiazine degradation.RSC advances · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced oxidation processes (AOPs) based on PMS have been used to degrade various refractory pollutants such as drugs, endocrine disruptors, dyes and perfluorinated compounds due to their wide application range, mild reaction conditions, fast reaction rate and simple operation. In this study, tetracycline hydrochloride (TCH) was degraded based on this method. Magnetic MnFe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.